| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/26/2013 | WO2013106844A3 Methods and compositions for the treatment and diaginosis of pancreatic cancer |
| 09/26/2013 | WO2013045913A3 Fluid determination in a well bore |
| 09/26/2013 | WO2013034255A3 Method for establishing the presence of specified characteristics of a container product and device for performing said method |
| 09/26/2013 | WO2013026677A8 Ir spectrometry cell with temperature control means |
| 09/26/2013 | WO2012078365A3 Biomarkers for prediction of breast cancer |
| 09/26/2013 | US20130253358 System and method for remote collection and analysis of volatile organic components in breath |
| 09/26/2013 | US20130253187 Process for Determining the Suitability for Distribution of a Batch of Thiophene-2-Carboxamide Derivative |
| 09/26/2013 | US20130253036 Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua |
| 09/26/2013 | US20130253035 Camkk-beta as a target for treating cancer |
| 09/26/2013 | US20130252983 Activating phosphorylation site on glutaminase c |
| 09/26/2013 | US20130252957 Pyridinone antagonists of alpha-4 integrins |
| 09/26/2013 | US20130252950 Targeting mtor substrates in treating proliferative diseases |
| 09/26/2013 | US20130252898 Method and compositions for the treatment and detection of endothelin-1 related kidney diseases |
| 09/26/2013 | US20130252888 Use of imp3 as a prognostic marker for cancer |
| 09/26/2013 | US20130252852 Oligonucleotides Related to Lipid Membrane Attachment |
| 09/26/2013 | US20130252848 Cellomics system |
| 09/26/2013 | US20130252847 Assay assembly and method |
| 09/26/2013 | US20130252846 Screening method |
| 09/26/2013 | US20130252843 Method of making and using fluorescent-tagged nanoparticles and microarrays |
| 09/26/2013 | US20130252842 Methine-Substituted Cyanine Dye Compounds |
| 09/26/2013 | US20130252841 Arrayed detector system for measurement of anti-viral immune response |
| 09/26/2013 | US20130252840 Liquid tissue preparation from histopathologically processed biologically samples, tissues and cells |
| 09/26/2013 | US20130252839 Markers of primary graft dysfunction |
| 09/26/2013 | US20130252838 Target for breast cancer thereapy and/or diagnosis |
| 09/26/2013 | US20130252837 Method for measuring resistance or sensitivity to docetaxel |
| 09/26/2013 | US20130252836 Diagnostic test for cardiomyopathy |
| 09/26/2013 | US20130252834 Diagnostic Methods |
| 09/26/2013 | US20130252833 Drg11-responsive (dragon) gene and uses thereof |
| 09/26/2013 | US20130252829 Parallel Methods For Insertional Mutagenesis |
| 09/26/2013 | US20130252347 Diagnostic method |
| 09/26/2013 | US20130252346 Highly Sensitive System and Method for Analysis of Troponin |
| 09/26/2013 | US20130252341 Method and device for detecting nucleic acid, and kit |
| 09/26/2013 | US20130252322 Dry chemistry, lateral flow-reconstituted chromatographic enzyme-driven assays |
| 09/26/2013 | US20130252320 Modular point-of-care devices, systems, and uses thereof |
| 09/26/2013 | US20130252280 Method and apparatus for identification of biomolecules |
| 09/26/2013 | US20130252276 Sample analyzer and computer program product |
| 09/26/2013 | US20130252270 Toxicity screening methods |
| 09/26/2013 | US20130252267 Urine and serum biomarkers associated with diabetic nephropathy |
| 09/26/2013 | US20130252266 P-selectin associated with eosinophils as a marker for asthma and correlating with b-1 integrin activation |
| 09/26/2013 | US20130252265 Method for testing for cerebral infarction via cartilage acidic protein 1 |
| 09/26/2013 | US20130252264 Methods and compositions for the evaluation of renal injury using hyaluronic acid |
| 09/26/2013 | US20130252263 Methods of measuring adamts 13-mediated in vivo cleavage of von willebrand factor and uses thereof |
| 09/26/2013 | US20130252260 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom |
| 09/26/2013 | US20130252259 Methods for the Detection of Circulating Tumor Cells |
| 09/26/2013 | US20130252258 Rapid screening of monoclonal antibodies |
| 09/26/2013 | US20130252257 Quantification of circulating stem and progenitor cells as a means of assessing efficacy of naturopathic interventions |
| 09/26/2013 | US20130252256 Fusion protein having luminescence activity |
| 09/26/2013 | US20130252254 Procalcitonin gene expression as a precise biomarker of aging process |
| 09/26/2013 | US20130252252 Cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof |
| 09/26/2013 | US20130252251 Method for the diagnosis and/or prognosis of inflammatory states |
| 09/26/2013 | US20130252250 Cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof |
| 09/26/2013 | US20130252247 Kit for screening for skin-activating substances and comprising the klotho gene, and method for screening for skin-activating substances using the same |
| 09/26/2013 | US20130252245 Method for detecting the presence of a gynaecological growth |
| 09/26/2013 | US20130251751 Method for identifying immunoreactive peptides |
| 09/26/2013 | US20130251748 Use of outer membrane porin k36 protein (ompk36) in treatment/prevention/diagnosis of enterobacteriaceae infection |
| 09/26/2013 | US20130251739 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/26/2013 | US20130251738 Vaccines |
| 09/26/2013 | US20130251735 Sclerostin and the inhibition of wnt signaling and bone formation |
| 09/26/2013 | US20130251706 Combined use of fc gamma riib (cd32b) and cd20 - specific antibodies |
| 09/26/2013 | US20130251704 Monoclonal antibodies against orthopoxviruses |
| 09/26/2013 | US20130251702 Method for screening compounds for treating sepsis targeting nod2 signalling pathway and composition for treating sepsis comprising nod2 signalling pathway inhibitors |
| 09/26/2013 | US20130251694 Hepatocyte production by forward programming |
| 09/26/2013 | US20130251664 1L1RL-1 as a Cardiovascular Disease Marker and Therapeutic Target |
| 09/26/2013 | US20130251637 Fluorescent compounds |
| 09/26/2013 | US20130251234 Method for imaging and differential analysis of cells |
| 09/26/2013 | US20130250281 Lubricant deterioration sensor |
| 09/26/2013 | US20130249569 Measurement of amount of solid in suspension |
| 09/26/2013 | US20130248380 Flexible Graphene Biosensor |
| 09/26/2013 | US20130247647 Electrical Apparatus Oil Sampler and Conditioner for Solid State Sensors |
| 09/26/2013 | US20130247643 Method of calibrating an air sensor |
| 09/26/2013 | DE112012000326T5 Blutseparations-System und -Verfahren für einen Trockenteststreifen Blood separation system and method for a dry test strips |
| 09/26/2013 | DE102013204694A1 Verfahren zum Ermitteln eines Wiederherstellungszustands einer Metalllegierung A method for determining a state of a recovery metal alloy |
| 09/26/2013 | DE102012204493A1 Synthetic waste oil useful e.g. for determining effect of ethanol-containing fuel on components of motor vehicle, which are contacted with engine oil, comprises ethanol, water, fuel components, organic acid, mineral acid, and engine oil |
| 09/25/2013 | EP2642326A2 Automatic calibration of a microscope scanning system |
| 09/25/2013 | EP2642297A1 Hydroxy-sphingomyelin 22:1 as biomarker for healthy ageing |
| 09/25/2013 | EP2642296A1 p-Cresol sulphate as biomarker for healthy ageing |
| 09/25/2013 | EP2642295A1 1-O-alkyl-2-acylglycerophosphocholine (PC-O) 40:1 as biomarker for healthy ageing |
| 09/25/2013 | EP2642294A1 Phenylacetylglutamine as biomarker for healthy ageing |
| 09/25/2013 | EP2642293A1 9-oxo-octadecadienoic acid (9-oxo-HODE)as as biomarker for healthy ageing |
| 09/25/2013 | EP2642292A1 Method for testing for cerebral infarction via cartilage acidic protein 1 |
| 09/25/2013 | EP2642291A1 Enzyme triggered redox altering chemical elimination (E-trace) immunoassay |
| 09/25/2013 | EP2642290A1 Glatiramer acetate human monocytic cell line-based potency assay |
| 09/25/2013 | EP2642289A1 Portable electronic device |
| 09/25/2013 | EP2642288A1 Profiling oligosaccharides associated with biological activities of heparin or heparin derivatives |
| 09/25/2013 | EP2641978A1 Tests to predict responsiveness of cancer patients to chemotherapy treatment options |
| 09/25/2013 | EP2641977A1 Tests to predict responsiveness of cancer patients to chemotherapy treatment options |
| 09/25/2013 | EP2641973A2 Method and associated system for detecting and analysing pathogenic agents and/or agents capable of causing the deterioration of food of vegetable origin |
| 09/25/2013 | EP2641914A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same |
| 09/25/2013 | EP2641094A2 Method and device for high-throughput solution exchange for cell and particle suspensions |
| 09/25/2013 | EP2641093A2 Glycopeptide-functionalized nanoparticle arrays for capturing and detecting biomolecules |
| 09/25/2013 | EP2641092A1 Prediction of a small-for-gestational age (sga) infant |
| 09/25/2013 | EP2641091A1 New animal model for diabetic complications |
| 09/25/2013 | EP2641090A1 Use of quinolinone derivatives as a research tool |
| 09/25/2013 | EP2641089A2 Novel gpr101 transgenic mice and methods of use thereof |
| 09/25/2013 | EP2641088A1 Device and method for immunotrials |
| 09/25/2013 | EP2641087A1 Magnetic flow cytometry for high sample throughput |
| 09/25/2013 | EP2641086A1 Method for screening drugs for suppressing inflammasome activity |
| 09/25/2013 | EP2641084A1 A guided structured testing kit |
| 09/25/2013 | EP2641080A1 Device and method for measuring biomarkers |
| 09/25/2013 | EP2641077A2 Hybrid, planar optofluidic integration |